search

UMD     This Site





Professor Benjamin Shapiro (BioE/ISR) has been awarded a three-year, $301K NSF Collaborative Research grant, Modeling and Control of Magnetic Chemotherapy.

The research aims to improve the delivery of chemotherapy drugs to target tumors. With existing chemotherapy, it is estimated that less than 0.1 percent of administered drugs are taken up by the tumor, while the remaining 99.9 percent go to healthy tissue, where they can cause severe and life-threatening side-effects. In magnetic drug targeting, chemotherapy can be attached to biocompatible magnetic particles. This allows magnetic control of the drugs: magnets placed outside the patient can potentially be used to focus the therapy to tumors.

Doing so is difficult. The human body is complex and it is not yet understood how to actuate the magnets (when to turn them on and off) to best direct the drugs to the tumors. The goal of this project is to develop sophisticated and experimentally-validated tools to better understand how magnetized chemotherapy moves through the body, and based on these to develop methods to optimally actuate the magnets to better direct the chemotherapy to tumors.

The broader impact will be a suite of techniques to improve magnetic drug targeting - potentially moving it from a method that could only focus drugs to single shallow tumors, to one that could access deep tumors as well as small and poorly vascularized metastatic tumors spread throughout the body.



Related Articles:
Shapiro, Martin awarded MPowering seed grant for novel study of cancer cells' 'microtentacles'
Shapiro, Depireux team for series of grants to combat hearing loss
McAvoy, Researchers Investigate Link between Bacteria and Cancer of the Appendix
Didier Depireux wins inaugural Provost's Excellence Award
Ben Shapiro shows pulsing magnetic fields could push drugs to deep targets
Nacev, Chowdhury place in 2013 Dean's Doctoral Student Research Award competition
Two BioE/ISR Professors Receive Maryland Industrial Partnership Funding
Shapiro wins NSF grant for assembly of colloidal crystals

July 15, 2013


«Previous Story  

 

 

Current Headlines

Ingestible Capsule Advances May Lead to Earlier Detection of Diseases

University of Maryland Moves Ahead in Its Leadership of the United States' Semiconductor Industry

Srivastava Named Inaugural Director of Semiconductor Initiatives and Innovation

State-of-the-Art 3D Nanoprinter Now at UMD

UMD, Partners Receive $31M for Semiconductor Research

Two NSF Awards for ECE Alum Michael Zuzak (Ph.D. ’22)

Applications Open for Professor and Chair of UMD's Department of Materials Science and Engineering

Ghodssi Honored With Gaede-Langmuir Award

Milchberg and Wu named Distinguished University Professors

New features on ingestible capsule will deliver targeted drugs to better treat IBD, Crohn’s disease

 
 
Back to top  
Home Clark School Home UMD Home